Insiders who reported open-market trades in the last 12 months at the companies Walter V. Klemp files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Walter V. Klemp is a corporate insider, tracked as CEO and President, Director of Moleculin Biotech, Inc. (MBRX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Walter V. Klemp submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Walter V. Klemp been buying or selling stock?
Recorded transactions: 1 open-market purchase and 0 open-market sales across all tracked filings.
Walter V. Klemp is CEO and President, Director of Moleculin Biotech, Inc. (MBRX). 8 SEC Form 4 filings on record going back to 2024, most recently on 17 October 2026.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Walter V. Klemp.
InsiderAlpha's records for Walter V. Klemp go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
